ELITE PHARMACEUTICALS INC /NV/ Quarterly Preferred Stock, Par or Stated Value Per Share in USD/shares from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD/shares
Description
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Preferred Stock, Par or Stated Value Per Share history and growth rate from Q1 2019 to Q4 2022.
  • Elite Pharmaceuticals Inc /Nv/ Preferred Stock, Par or Stated Value Per Share for the quarter ending December 31, 2022 was 0.01 USD/shares, unchanged year-over-year.
Preferred Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Preferred Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0.01 $0 0% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $0.01 $0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0.01 $0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $0.01 $0 0% Mar 31, 2022 10-Q 2023-02-14
Q4 2021 $0.01 $0 0% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $0.01 $0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $0.01 $0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $0.01 $0 0% Mar 31, 2021 10-Q 2022-02-14
Q4 2020 $0.01 $0 0% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $0.01 Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $0.01 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $0.01 $0 0% Mar 31, 2020 10-K 2021-06-14
Q4 2019 $0.01 Dec 31, 2019 10-Q 2020-02-10
Q1 2019 $0.01 Mar 31, 2019 10-K 2020-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.